Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $143.2600 (-7.64%) ($143.1900 - $143.2600) on Thu. Dec. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.79% (three month average) | RSI | 36 | Latest Price | $143.2600(-7.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.8% a day on average for past five trading days. | Weekly Trend | LGND declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(61%) IWO(61%) IWM(59%) IWC(56%) IWN(55%) | Factors Impacting LGND price | LGND will decline at least -1.395% in a week (0% probabilities). VIXM(-28%) UUP(-19%) VXX(-17%) UNG(-5%) TBT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.395% (StdDev 2.79%) | Hourly BBV | -2.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $157.76 | 5 Day Moving Average | $150.56(-4.85%) | 10 Day Moving Average | $153.77(-6.83%) | 20 Day Moving Average | $157.76(-9.19%) | To recent high | -13.6% | To recent low | 12.3% | Market Cap | $2.302b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |